Compounds > testolactone
Page last updated: 2024-08-21

testolactone and Testicular Neoplasms

testolactone has been researched along with Testicular Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Apaydin, S; Kara, C; Kutlu, AO; Senel, F; Tosun, MS1
Akcoren, Z; Alikasifoglu, A; Ciftci, AO; Gonc, EN; Kale, G; Senocak, ME; Yordam, N1

Other Studies

2 other study(ies) available for testolactone and Testicular Neoplasms

ArticleYear
Sertoli cell tumor causing prepubertal gynecomastia in a boy with peutz-jeghers syndrome: the outcome of 1-year treatment with the aromatase inhibitor testolactone.
    Hormone research, 2005, Volume: 63, Issue:5

    Topics: Aromatase Inhibitors; Child; Gynecomastia; Humans; Male; Nephrocalcinosis; Peutz-Jeghers Syndrome; Sertoli Cell Tumor; Testicular Neoplasms; Testolactone

2005
Feminizing Sertoli cell tumor associated with Peutz-Jeghers syndrome.
    Journal of pediatric endocrinology & metabolism : JPEM, 2002, Volume: 15, Issue:4

    Topics: Antineoplastic Agents, Hormonal; Child; Gynecomastia; Hormones; Humans; Ileum; Intestinal Polyps; Male; Peutz-Jeghers Syndrome; Pigmentation Disorders; Sertoli Cell Tumor; Testicular Neoplasms; Testolactone

2002